We are live on ! Find out more
STML

Stemline Therapeutics, Inc.
STML

Delisted

STML was delisted on the 9th of June, 2020.

Back to rankings

56 hedge funds and large institutions have $184M invested in Stemline Therapeutics, Inc. in 2013 Q2 according to their latest regulatory filings, with 56 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
56
Holders Change
+56
Holders Change %
–
% of All Funds
1.82%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
56
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

STML Hedge Fund Activity: Q2 2013 in Review

56 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Stemline Therapeutics, Inc. (STML) for Q2 2013, worth a combined $184M.

Buyers outnumbered sellers: 56 funds opened new STML positions and 0 closed out — a net gain of 56 holders — while 0 added to existing stakes and 0 trimmed.

  • 56 institutional investors held Stemline Therapeutics, Inc. (STML) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $184M of Stemline Therapeutics, Inc. stock for Q2 2013.
  • 56 funds opened new Stemline Therapeutics, Inc. positions in Q2 2013 and 0 closed out, a net change of +56 holders.

Based on aggregated 13F filings for Q2 2013.